Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference
December 26, 2024 12:21 ET
|
Tevogen Bio Inc
The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative...
Tevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare Conference
December 17, 2024 13:32 ET
|
Tevogen Bio Inc
WARREN, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...
Real-World Evidence and Life Science Analytics 2 Day Conference (Boston, USA - October 17th-18th 2024) - Shaping the Future of Healthcare
July 02, 2024 04:07 ET
|
Research and Markets
Dublin, July 02, 2024 (GLOBE NEWSWIRE) -- The "7th Annual Real-World Evidence and Life Sciences Analytics Conference" conference has been added to ResearchAndMarkets.com's offering. The 7th...
Real-World Evidence and Market Access Annual In-Person Conference (Germany - October 14-15th, 2024): Anticipated Regulatory Updates and RWE Impact on Market Access
June 27, 2024 07:35 ET
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "2nd Annual Real-World Evidence and Market Access Conference" has been added to ResearchAndMarkets.com's offering. The Real-World Evidence and Market...
MEWA Health Economics & Outcomes Research (HEOR) Services Market Analysis to 2030 - IT, AI, and Advancements Reshape Delivery Systems, Unleashing Opportunities for Market Growth
January 25, 2024 12:15 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "MEWA Health Economics & Outcomes Research Services Market Size and Forecast, Regional Share, Trends, and Growth Opportunity Analysis Coverage: By...
New economic analysis of Voraxaze® (glucarpidase) in patients with delayed methotrexate
March 15, 2023 09:58 ET
|
BTG Specialty Pharmaceuticals
West Conshohocken, PA, March 15, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, today announces the publication of an economic simulation assessing the value of Voraxaze®...
Lumanity Expands Medical Affairs Capabilities
January 30, 2023 08:00 ET
|
Lumanity
LUMANITY EXPANDS MEDICAL AFFAIRS CAPABILITIES Enhanced solutions to deliver effective medical strategies, cross-functional communication plans, and programs to connect with patients and providers ...
Health Economics & Outcomes Research Services Market to surpass $3.5 billion by 2032, says Global Market Insights Inc.
January 24, 2023 04:34 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Health economics & outcomes research services market value is projected to cross USD 3.5 billion by 2032, as per a recent research...
Health Care Consulting Leader Monument Analytics Will Change Its Name to Stage Analytics™
January 05, 2023 09:00 ET
|
Stage Analytics™
ATLANTA, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Health care consulting leader Monument Analytics announces that it has changed its name to Stage Analytics™. The new name captures the importance of...
Clinigen adds pharmacovigilance capabilities with acquisition of Drug Safety Navigator
November 29, 2022 02:00 ET
|
Clinigen
November 29, 2022 Clinigen adds pharmacovigilance capabilities with acquisition of Drug Safety Navigator Clinigen Limited (‘Clinigen’ or the ‘Company’), the global pharmaceutical services...